Fundraising Fox

Korro Bio

NASDAQ: KRRO

Cambridge, US · Founded 2018 · Delaware corporation · 77 employees on LinkedIn · 15 known investors

Find your way into Korro Bio

734 people in our graph share verified history with the Korro Bio team — schools, employers, funds. One of them is your warm intro.

Dan Lynchunlockedknows Nessan Bermingham · together at Xilio Therapeutics (overlapped)
knows the team · via Atlas Venture
×2knows the team · via PwC
×7knows the team · via Khosla Ventures
knows the team · via F-star Therapeutics, Inc.

Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.

BiotechHealthtech

Founders & leadership

Korro Bio was founded in 2018 by Nessan Bermingham and Jean-François Formela.

NBNessan Bermingham
Nessan BerminghaminFounder & Exec ChairNessan Bermingham has spent nearly three decades in life sciences, founding and leading multiple biotechnology companies including Intellia Therapeutics (which went public), as well as Korro Bio, Stylus Medicine, Liberate Bio, Excelsior Sciences, and EveryOne Medicines, with expertise spanning gene editing, RNA therapeutics, cell therapy, and drug discovery.
JFJean-François Formela
Jean-François FormelainCo-founderPartner at Atlas Venture
OCOmmer Chohan
Ommer ChohaninMr. Chohan is the Secretary and Treasurer of the Issuer.CFO at Atlas Venture
RARam Aiyar
Ram AiyarinChief Executive OfficerHe brings experience in drug development, financial analysis, and healthcare entrepreneurship, with a background in building multidisciplinary teams for therapeutic programs and developing commercial strategies for healthcare startups.
TCTodd Chappell
Todd ChappellinChief Operating OfficerHe holds a B.S. in biology from UCLA and an MBA from Boston University, and has spent fifteen years in molecular biology research and life sciences business strategy.

Board

JFJean-Francois Formela
Jean-Francois FormelainBoard directorGeneral Partner at Atlas Venture

Investors · 15

Atlas VentureCambridge · $500K – $1Mvia Jean-François Formela · board
MC Healthcare VenturesCambridge
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Alexandriareported · 2 sourcesPasadena
Qiming Venture Partners USAreportedCambridge
Rock Springs CapitalreportedBaltimore
Taiwania CapitalreportedTaipei · $3M – $85M
Wu Capitalreported

Also in the syndicate · 7

Blue Owl Healthcare OpportunitiesCormorant Asset ManagementDeep Track CapitalleadMP Healthcare Venture ManagementSurveyor Capital (a Citadel company)Tri Locum PartnersVenrock Healthcare Partnerslead

Funding

SEC filings, press & company announcements

$4M disclosed across 1 of 5 rounds · 2019–2026

▶$4MraisedJun 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nessan BerminghamExecutive Officer, Director, Promoter
  • Ommer ChohanExecutive Officer, Director, Promoter
  • Jean-Francois FormelaDirector
Offering amount
$4M
Amount sold
$4M
First sale
May 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Korro Bio went on to found or lead other companies.

Nessan BerminghamMr. Bermingham is the Executive Chair of the Issuer.Founded Intellia Therapeutics +1Stuart MilsteinVice President Platform BiologyFounded AerskaAndrew FraleyFounder & CTOFounded Judo Bio

Competitors · 3

by search overlap
Bridgebio29 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
bio23 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Robinhood23 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.

Companies competing with Korro Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Korro Bio Raises $85M After Pivoting to GalNAc RNA Editing — BigGo Financefinance.biggo.com · Apr 2026Korro Bio Inc (KRRO)morningstar.com · Mar 2026Korro Bio raises $85 million in private equity financing By Investing.cominvesting.com · Mar 2026Korro Bio Raises $70 Million to Advance RNA Edited Therapies - Global Genesglobalgenes.org · Apr 2024Korro Bio Raises $116 Million to Advance Pipeline of RNA Editing Programs - Global Genesglobalgenes.org · Jan 2022RNA Therapeutics Company Korro Bio Raises $91.5 Millionpulse2.com · Sep 2020

Frequently asked questions

What does Korro Bio do?
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.
Who founded Korro Bio?
Korro Bio was founded by Nessan Bermingham, Jean-François Formela in 2018.
Who are Korro Bio's investors?
Korro Bio's investors include Atlas Venture, MC Healthcare Ventures, New Enterprise Associates (NEA), Alexandria, Qiming Venture Partners USA, Rock Springs Capital, Taiwania Capital, Wu Capital.
How much funding has Korro Bio raised?
Korro Bio has disclosed $4M raised across 1 of its 5 known rounds.
Where is Korro Bio headquartered?
Korro Bio is headquartered in Cambridge, US.